[Hemodynamics and ergometric performance modified by low dosage oral contraceptives]

Area of Science:

• Exercise Physiology
• Reproductive Endocrinology

Context:

• Understanding the impact of hormonal fluctuations on physiological responses during exercise is crucial for female athletes and active individuals.
• Low-dosed oral contraceptives (OC) alter endogenous hormone profiles, potentially influencing cardiovascular and metabolic responses.
• Previous research on OC effects on exercise hemodynamics has yielded mixed results.

Purpose:

• To investigate the hemodynamic differences during exercise in women using low-dosed oral contraceptives (OC) compared to their normal menstrual cycles.
• To assess maximal watt performance, pulse work capacity at 170 beats per minute (PWC170), and resting/exercise blood pressure and heart rate.

Summary:

• This pilot study compared hemodynamic parameters in 6 women during bicycle ergometry in normal (N) cycles versus cycles on low-dosed OC.
• No significant differences were observed in the follicular or mid-cycle phases.
• During the luteal phase, significantly higher heart rates and blood pressure were recorded during exercise in N cycles compared to OC cycles (p < 0.05).

Impact:

• Findings suggest that low-dosed oral contraceptives may attenuate the luteal phase increase in heart rate and blood pressure during submaximal exercise.
• This information can inform exercise prescription and performance expectations for women using oral contraceptives.
• Further research is warranted to confirm these findings in larger, diverse populations and explore underlying mechanisms.